Advanced search
Publication Cover
Autoimmunity Volume 39, 2006 - Issue 8
Submit an article Journal homepage
171
Views
9
CrossRef citations to date
0
Altmetric
Original

Immunomodulation of experimental pulmonary fibrosis by intravenous immunoglobulin (IVIG)

Vered Molina Department of Medicine ‘B’, The Sackler School of Medicine, The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel-Aviv, Israel
,
Saleem Haj-Yahia Department of Medicine ‘B’, The Sackler School of Medicine, The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel-Aviv, Israel; Imperial College School of Medicine, Royal Brompton and Harefield Hospital, University of London, London, UK
,
Inna Solodeev Department of Medicine ‘B’, The Sackler School of Medicine, The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel-Aviv, Israel
,
Yair Levy Department of Medicine ‘B’, The Sackler School of Medicine, The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel-Aviv, Israel
,
Miri Blank Department of Medicine ‘B’, The Sackler School of Medicine, The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel-Aviv, Israel
&
Yehuda Shoenfeld Department of Medicine ‘B’, The Sackler School of Medicine, The Center for Autoimmune Diseases, Sheba Medical Center, Tel-Hashomer, Tel-Aviv University, Tel-Aviv, Israel; Incumbent of the Laura Schwarz-Kipp Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel-Aviv, Israel
Pages 711-717 | Received 28 Dec 2005, Accepted 17 May 2006, Published online: 07 Jul 2009

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

N Farina, C Campochiaro, A Lescoat, G Benanti, G De Luca, D Khanna, L Dagna & M Matucci-Cerinic. (2023) Drug development and novel therapeutics to ensure a personalized approach in the treatment of systemic sclerosis. Expert Review of Clinical Immunology 19:9, pages 1131-1142.
Read now

Articles from other publishers (8)

Nils Erik Gilhus, Socrates Tzartos, Amelia Evoli, Jacqueline Palace, Ted M. Burns & Jan J. G. M. Verschuuren. (2019) Myasthenia gravis. Nature Reviews Disease Primers 5:1.
Crossref
Panpan Qian, Chun hong Peng & Xianwei Ye. (2019) Interstitial pneumonia induced by cyclophosphamide: A case report and review of the literature. Respiratory Medicine Case Reports 26, pages 212-214.
Crossref
Annick De Weerdt, Amélie Dendooven, Annemie Snoeckx, Jan Pen, Martin Lammens & Philippe G. Jorens. (2017) Prognosis and treatment of FOLFOX therapy related interstitial pneumonia: a plea for multimodal immune modulating therapy in the respiratory insufficient patient. BMC Cancer 17:1.
Crossref
Lazaros I. Sakkas & Dimitrios P. Bogdanos. (2016) Systemic sclerosis: New evidence re-enforces the role of B cells. Autoimmunity Reviews 15:2, pages 155-161.
Crossref
Aggeliki D Sali, Ioannis Karakasiliotis, Maria Evangelidou, Stratis Avrameas & Peggy Lymberi. (2015) Immunological evidence and regulatory potential for cell-penetrating antibodies in intravenous immunoglobulin. Clinical & Translational Immunology 4:10, pages e42.
Crossref
H. Schmidt, P. Schramm, Th. Fuchs, M. Bähr & P. Lingor. (2011) Skleromyxödem Arndt-Gottron und EnzephalopathieArndt-Gottron syndrome with encephalopathy. Der Nervenarzt 82:10, pages 1325-1329.
Crossref
Jeanmarie B. Rey & Rebecca B. Luria. (2009) Treatment of scleromyxedema and the dermatoneuro syndrome with intravenous immunoglobulin. Journal of the American Academy of Dermatology 60:6, pages 1037-1041.
Crossref
Petros Efthimiou & Michelle Blanco. (2008) Intravenous Gammaglobulin and Thalidomide May Be an Effective Therapeutic Combination in Refractory Scleromyxedema: Case Report and Discussion of the Literature. Seminars in Arthritis and Rheumatism 38:3, pages 188-194.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.